Non-ST-segment elevation myocardial infarctions (NSTEMI) are common and cause significant morbidity and mortality. Following evidence-based medicine (EBM) guidelines is one way to ensure that these patients are cared for appropriately. This pilot study examined data from patients with NSTEMI to assess both documentation quality and use of EBM across multiple teams. Medical records were reviewed for significant differences in documentation quality in areas including history and physical exam, treatment, and inpatient mortality. While total documentation quality and mortality were not significantly different between groups, cardiology teams adhered to evidence-based recommendations more often than other teams. L ack of proper documentation has been associated with poor patient outcomes. Cox et al found that documentation of cardiac risk factors was quite poor when reviewing history and physical documentation for patients hospitalized for myocardial infarction and congestive heart failure. It was even worse in the elderly and females (1) . Th e absence of documented cardiovascular risk factors has led to higher mortality in non-ST-segment elevation myocardial infarctions (NSTEMI) (2) . It was unknown locally how well physicians at Scott & White Memorial Hospital, part of the Baylor Scott & White Health system, document in these situations. Th is quality improvement study examined medical record documentation associated with three types of inpatient medicine treatment teams to determine if there were diff erences in documentation and use of evidence-based medicine (EBM) across provider teams.
METHODS
Th is study was approved by the institutional review board at Scott & White Healthcare. Th is was a retrospective chart review designed to examine the following questions: 1) In a comparison of cardiology, nonteaching, and teaching teams, which team scored higher in the quality of the medical record documentation and EBM use? 2) Does better physician documentation translate into a decrease in patient mortality at our institution?
Th e study took place at Scott & White Memorial Hospital in Temple, Texas, a 636-bed hospital part of an integrated health care system in Central Texas. Medical records of patients aged 18 to 99 with a primary diagnosis of NSTEMI who were admitted to our teaching, nonteaching, or cardiology teams between January 1, 2006, and December 31, 2009, were eligible for inclusion. Inclusion dates were chosen by the research team based upon when team structure, guidelines, and medical record systems were the most stable. After this timeframe, many changes in the institution occurred that did not allow for a long enough period of stability. Exclusion criteria included sepsis, demand infarction, NSTEMI as a secondary diagnosis, admission to a non-internal medicine team, and a troponin level <0.04 ng/mL. Based upon these criteria, 442 patients with a diagnosis of NSTEMI were initially included in this study.
Teaching teams comprised internal medicine residents and a hospitalist attending; nonteaching teams comprised a midlevel provider and a hospitalist; and cardiology teams comprised residents, fellows, and cardiology attendings.
As part of a mentored research grant at Scott & White/ Texas A&M Health Sciences Center College of Medicine, the fi rst author, who was an internal medicine resident at the time, conducted a retrospective chart review to examine the quality of medical record documentation and use of EBM across teams that cared for NSTEMI patients. Th e authors compared teams' use of EBM and documentation in the history, physical exam, lab fi ndings, and tests performed. Th e purpose of this quality improvement project was to determine which team (cardiology, teaching, nonteaching inpatient team) needed the most improvement in documentation and EBM use.
Th e history and physical checklist used in this study was based upon a 20-point rating scale developed by Dunlay et al (3) . Th e scale was modifi ed to include 25 items evaluating the history and physical, as well as fi ve items designed to evaluate the use of EBM. Th e modifi ed scale included an expanded history and physical checklist, with a maximum score of 30, compared
Comparison of documentation and evidence-based medicine use for non-ST-segment elevation myocardial infarction among cardiology, teaching, and nonteaching teams pairwise comparison when signifi cant diff erences were detected. A P value of <0.05 was the threshold for statistical signifi cance. SAS version 9.2 (SAS Institute Inc., Cary, NC) was used for data analysis.
RESULTS
Based upon a retrospective review of 442 charts of patients with a diagnosis of NSTEMI and a troponin level >0.04 ng/ mL, 252 (57.0%) were NSTEMI cases that had been treated by one of the three teams. Excluded were 91 cases (20.6%) with ST-elevation myocardial infarctions, 59 cases (12%) treated by teams not in the study, and 40 cases (9%) wherein myocardial infarction was a secondary diagnosis.
Among patients with NSTEMI as a primary diagnosis (N = 252), 151 cases (60%) were treated by a cardiology team, 60 cases (24%) were treated by a teaching team, and 41 cases (16%) were treated by a nonteaching team. Based on pairwise comparisons, the nonteaching team had older patients than the cardiology team, who had signifi cantly more male patients than the teaching team. Th ere were no signifi cant diff erences in other demographics across teams (Table 1) .
Th e three teams diff ered signifi cantly on EBM use (P < 0.0001). Based on Bonferroni-adjusted pairwise comparisons, cardiology had a signifi cantly higher mean EBM score than the other teams. No signifi cant diff erences were detected among the three teams in total history and physical score (0-25) or the 30-item total score (Table 2, Figure 1 ).
Signifi cant diff erences were also found on eight of 30 history and physical checklist items (Table 3) . Teams diff ered signifi cantly on documentation of the following items: type and duration of pain; whether the pain had ever occurred before; social history of activity; chest x-ray results; whether lipids, glucose, or A1C were mentioned; diff erential diagnosis; treatment of other comorbidities; and the use of glycoprotein IIb/ IIIa inhibitors. No signifi cant diff erences were detected across teams on other items. Social history of activity and diff erential diagnosis were found in only 45 subjects (18%), and those items were documented least often. Pulmonary exam was listed for all subjects in the cohort, and it was most often documented.
DISCUSSION
Th e Can Rapid Risk Stratifi cation of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) initiative is being conducted at multiple institutions across the country and deals with the care of patients with unstable angina and NSTEMI. Several studies that referenced the CRUSADE database analyzed the quality of medical record documentation and EBM use within their own institutions (4).
Dunlay et al utilized CRUSADE data to evaluate the quality of documentation, use of EBM, and mortality rates when comparing academic versus nonacademic hospitals, and cardiologists versus noncardiologists. Results showed that academic institutions and cardiologists scored higher than their counterparts, and these higher scores demonstrated better use of EBM to 20 in the Dunlay study. Th e additional items covered were EBM, history of present illness, chief complaint, type and duration of pain, past medical history including lipids or previous cardiac imaging, family history, social history including drug and activity, and adding electrocardiogram and chest x-ray to studies. We excluded creatinine from labs and removed the problem list. Unlike the Dunlay study, partial credit for items was not given in this quality improvement study.
Charts were reviewed and scored using the initial history and physical. Each chart was reviewed and the history and physical was evaluated using the 30-point checklist described above. Use of EBM was determined on a 5-point scale and inpatient mortality was recorded. Patient team data (teaching, nonteaching, cardiology) and demographics were also recorded for each patient. For patients who were admitted overnight by hospitalists, the team recorded was the team to which they were assigned.
Specifi c criteria were used when examining each variable within the history and physical. For example, the chief complaint must have been listed specifi cally. A description of the type and duration of the complaint must have been listed, as well as any associated symptoms. Th e history of present illness was also inspected for mention of prior events like the current one. Th e medical history was reviewed for mention of current medical problems, recent lipid panels or hemoglobin A1C, or previous stress tests or angiograms or lack thereof. In the family history, the physician must have discussed the age at which a relative had a myocardial infarction, and other family history was counted as a separate item. Documentation of social history must have contained a positive or negative response to any drug, which includes alcohol, tobacco, and illegal drugs. A separate point was given if physical activity was included. Individual portions of the physical exam included vital signs, cardiovascular exam, respiratory exam, and peripheral vascular exam (peripheral pulses). For labs and studies, we concentrated on cardiac enzymes, electrocardiogram, chest x-ray, and hemoglobin. We also examined lipid, glucose, and hemoglobin A1C values.
Th e assessment and plan were reviewed for a diff erential diagnosis, fi ve specifi c evidence-based therapies for NSTEMI, and treatments of other comorbidities. We reviewed for the following fi ve specifi c therapies: aspirin, beta-blockers, heparin or a heparinoid, statin on discharge, and glycoprotein IIb/IIIa inhibitors. One point each was given if these were mentioned in the assessment and plan by documenting use or reason for not using. Angiotensin-converting enzyme inhibitors were not included due to specifi c requirements about ejection fraction. Clopidogrel was not included on the checklist since eptifi batide was the preferred agent when providers anticipated invasive management during this time period.
All variables, including 30 checklist items, overall checklist scores, and patient demographics, were summarized according to care team using descriptive statistics: mean for continuous variables and frequency for categorical variables. Th e three care teams were compared utilizing analysis of variance or KruskalWallis test for continuous variables. Chi-square test or Fisher's exact test was used to compare groups of categorical variables. Pairwise comparisons utilized Bonferroni adjustment or Tukey's and improved mortality rates (3). Patel et al (5) and O'Brien et al (6) found that academic institutions were better at following guidelines than nonacademic institutions, but they did not examine specifi c history and physical exam documentation. Bottorff et al (7) found that academic institutions were better at prescribing antiplatelet agents in the hospital than nonacademic institutions. Mehta et al (8) reported that once groups were in the CRUSADE trial and were notifi ed of their own results, adherence to guidelines drastically improved. One study showed that institutions that were accredited by the Society of Chest Pain Centers had better outcomes due to an improved use of EBM (9) . Th ese studies inspired us to assess documentation and EBM use within our institution and compare outcomes across care teams.
Based upon the results of our study, cardiology teams performed better than teaching and nonteaching teams in giving glycoprotein IIb/IIIa inhibitors. However, teaching teams performed better in discussing the results of chest x-rays and evaluating other comorbidities in the assessment and plan. Findings also indicated that nonteaching teams scored lower than cardiology teams in discussing the symptom type and duration, if the symptoms had ever occurred before, and use of glycoprotein IIb/IIIa inhibitors. Nonteaching teams performed better than cardiology teams at documenting a diff erential diagnosis. Th e only diff erence noted between teaching and nonteaching teams was the discussion of other comorbidities in the assessment and plan.
Th e present study design diff ered from previous studies in that we compared diff erent teams within the same hospital to determine if there were diff erences in quality of care and documentation. Also, while CRUSADE studies included patients with unstable angina, transient ST elevations, and NSTEMI who presented within 24 hours, our study included only NSTEMI whenever it presented.
Our results diff ered from other studies (10-12) in that we found no diff erence in medical record total scores or mortality among groups. Detecting diff erences in mortality between groups was diffi cult due to the small total number of deaths (N = 6). While other studies have found that teaching hospitals adhere to guidelines more frequently than nonteaching hospitals (5, 13, 14) , our fi ndings indicated there was no signifi cant diff erence between our teaching and nonteaching teams in EBM use. Overall documentation did not seem to infl uence EBM use. Th e quality of documentation on medicine teams at our institution appears to be similar to that reported in the Dunlay study (3). In our facility, mean scores were 17.7/25 (70.8%) for the history and physical score and 21.8/30 (72.6%) for history and physical score with EBM added. Dunlay et al (3) reported a mean score of 12.5/20 (62.5%). Our fi ndings appear to mirror those of Dunlay et al (3) in that cardiology teams adhered to EBM guidelines signifi cantly more than other teams. However, this diff erence appears to be due to the use of glycoprotein IIb/IIIa inhibitors, which was also found in another study (7) . Th e reason may be lack of knowledge of this particular guideline or a discomfort in prescribing additional blood thinners. We also found that patients treated by the cardiology team were signifi cantly younger and more often male than those served by noncardiology teams, which is similar to demographics seen in other studies (5, 11, 12) . Diff erences from the Dunlay study include that this retrospective study was performed at one site with a small population. Only NSTEMI patients confi rmed with a troponin level >0.04 ng/mL were included in our study. Th e small sample size could inhibit our ability to detect diff erences among the teams. Another factor is that other teams in our facility had patients with NSTEMI, but these were excluded in order to compare only medicine teams. Our rating scale was based upon a scale used in the Dunlay study, but was not validated, which could be a limitation.
In an attempt to improve the overall quality of patient care, medicine teams have been notifi ed of the results, and we will reevaluate the documentation and use of EBM across provider teams. Since the onset of the study, the use of certain medications upon admission to the hospital for NSTEMI patients has changed. Th e frequency of glycoprotein IIb/IIIa inhibitor use decreased during the study period, and it will be removed from future checklists. We believe this may be related to results of the ACUITY Timing trial (15) and EARLY ACS study (16) , as well as the increasing use of bivalirudin in the catheterization lab. Most NSTEMI patients at our institution undergo an early invasive strategy and now receive clopidogrel, ticagrelor, or prasugrel as a second antiplatelet agent. Use of a b Figure 1 . Distribution of history and physical scores (a) with and (b) without the evidence-based medicine score added. these medications will be tracked in future studies. To enhance generalizability of fi ndings, we hope to collaborate with other teaching institutions. Our quality improvement study demonstrated that cardiology teams at Scott & White/Texas A&M adhered to EBM guidelines more frequently than other medicine teams. Statistically signifi cant diff erences in mortality rates or documentation were not found. Th is study appears to be only the second to examine the infl uence of documentation on patient care in myocardial infarction (3) . A small improvement in mortality in a disease this common can translate to a large eff ect. Studies with an increased sample size may fi nd a diff erence related to documentation alone. Recent events in our institution have included the integration of a new electronic health record and the merger between Scott & White and Baylor Health Care Systems. Th ese two changes will allow for a larger study to be performed and likely an intervention including a standardized history and physical with order set to ensure appropriate use of EBM.
